[HTML][HTML] Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: a national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - thelancet.com
Background Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo… - The Lancet …, 2022 - univ-lyon1.hal.science
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - ephe.hal.science
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - hal.univ-smb.fr
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - hal.insa-toulouse.fr
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona, A Pariente… - 2022 - agris.fao.org
English. BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most
severe clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - hal.science
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - inria.hal.science
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo… - The Lancet …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study

N Ouldali, H Bagheri, F Salvo, D Antona… - The Lancet Regional …, 2022 - cnrs.hal.science
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …